Global Dementia and Alzheimer’s Disease Treatment Market Research Report 2023
Alzheimer’s disease is a chronic neurodegenerative disorder which results in gradual degradation of the tissues of the brain. This hampers the normal functioning of the brain and impacts the daily lives of patients.
According to QYResearch’s new survey, global Dementia and Alzheimer’s Disease Treatment market is projected to reach US$ 4311.3 million in 2029, increasing from US$ 3612 million in 2022, with the CAGR of 2.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dementia and Alzheimer’s Disease Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Dementia and Alzheimer’s Disease Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to QYResearch’s new survey, global Dementia and Alzheimer’s Disease Treatment market is projected to reach US$ 4311.3 million in 2029, increasing from US$ 3612 million in 2022, with the CAGR of 2.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dementia and Alzheimer’s Disease Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Dementia and Alzheimer’s Disease Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Novartis
- Pfizer, Inc.
- AbbVie Inc.
- Allergan plc
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- AstraZeneca
- Biogen
- Eisai Co., Ltd.
- INmuneBIO
- Cholinesterase Inhibitors
- Memantine
- Combination Drugs
- Hospital
- Clinic
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Cholinesterase Inhibitors
1.2.3 Memantine
1.2.4 Combination Drugs
1.3 Market by Application
1.3.1 Global Dementia and Alzheimer’s Disease Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Dementia and Alzheimer’s Disease Treatment Market Perspective (2018-2029)
2.2 Dementia and Alzheimer’s Disease Treatment Growth Trends by Region
2.2.1 Global Dementia and Alzheimer’s Disease Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Dementia and Alzheimer’s Disease Treatment Historic Market Size by Region (2018-2023)
2.2.3 Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Region (2024-2029)
2.3 Dementia and Alzheimer’s Disease Treatment Market Dynamics
2.3.1 Dementia and Alzheimer’s Disease Treatment Industry Trends
2.3.2 Dementia and Alzheimer’s Disease Treatment Market Drivers
2.3.3 Dementia and Alzheimer’s Disease Treatment Market Challenges
2.3.4 Dementia and Alzheimer’s Disease Treatment Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Dementia and Alzheimer’s Disease Treatment Players by Revenue
3.1.1 Global Top Dementia and Alzheimer’s Disease Treatment Players by Revenue (2018-2023)
3.1.2 Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Dementia and Alzheimer’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dementia and Alzheimer’s Disease Treatment Revenue
3.4 Global Dementia and Alzheimer’s Disease Treatment Market Concentration Ratio
3.4.1 Global Dementia and Alzheimer’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dementia and Alzheimer’s Disease Treatment Revenue in 2022
3.5 Dementia and Alzheimer’s Disease Treatment Key Players Head office and Area Served
3.6 Key Players Dementia and Alzheimer’s Disease Treatment Product Solution and Service
3.7 Date of Enter into Dementia and Alzheimer’s Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 DEMENTIA AND ALZHEIMER’S DISEASE TREATMENT BREAKDOWN DATA BY TYPE
4.1 Global Dementia and Alzheimer’s Disease Treatment Historic Market Size by Type (2018-2023)
4.2 Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Type (2024-2029)
5 DEMENTIA AND ALZHEIMER’S DISEASE TREATMENT BREAKDOWN DATA BY APPLICATION
5.1 Global Dementia and Alzheimer’s Disease Treatment Historic Market Size by Application (2018-2023)
5.2 Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Dementia and Alzheimer’s Disease Treatment Market Size (2018-2029)
6.2 North America Dementia and Alzheimer’s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2018-2023)
6.4 North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Dementia and Alzheimer’s Disease Treatment Market Size (2018-2029)
7.2 Europe Dementia and Alzheimer’s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2018-2023)
7.4 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size (2018-2029)
8.2 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Dementia and Alzheimer’s Disease Treatment Market Size (2018-2029)
9.2 Latin America Dementia and Alzheimer’s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2018-2023)
9.4 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size (2018-2029)
10.2 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Dementia and Alzheimer’s Disease Treatment Introduction
11.1.4 Novartis Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
11.1.5 Novartis Recent Development
11.2 Pfizer, Inc.
11.2.1 Pfizer, Inc. Company Detail
11.2.2 Pfizer, Inc. Business Overview
11.2.3 Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Introduction
11.2.4 Pfizer, Inc. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
11.2.5 Pfizer, Inc. Recent Development
11.3 AbbVie Inc.
11.3.1 AbbVie Inc. Company Detail
11.3.2 AbbVie Inc. Business Overview
11.3.3 AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Introduction
11.3.4 AbbVie Inc. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
11.3.5 AbbVie Inc. Recent Development
11.4 Allergan plc
11.4.1 Allergan plc Company Detail
11.4.2 Allergan plc Business Overview
11.4.3 Allergan plc Dementia and Alzheimer’s Disease Treatment Introduction
11.4.4 Allergan plc Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
11.4.5 Allergan plc Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Detail
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Introduction
11.5.4 Eli Lilly and Company Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
11.5.5 Eli Lilly and Company Recent Development
11.6 F. Hoffmann-La Roche Ltd.
11.6.1 F. Hoffmann-La Roche Ltd. Company Detail
11.6.2 F. Hoffmann-La Roche Ltd. Business Overview
11.6.3 F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Introduction
11.6.4 F. Hoffmann-La Roche Ltd. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
11.6.5 F. Hoffmann-La Roche Ltd. Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Dementia and Alzheimer’s Disease Treatment Introduction
11.7.4 AstraZeneca Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
11.7.5 AstraZeneca Recent Development
11.8 Biogen
11.8.1 Biogen Company Detail
11.8.2 Biogen Business Overview
11.8.3 Biogen Dementia and Alzheimer’s Disease Treatment Introduction
11.8.4 Biogen Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
11.8.5 Biogen Recent Development
11.9 Eisai Co., Ltd.
11.9.1 Eisai Co., Ltd. Company Detail
11.9.2 Eisai Co., Ltd. Business Overview
11.9.3 Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Introduction
11.9.4 Eisai Co., Ltd. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
11.9.5 Eisai Co., Ltd. Recent Development
11.10 INmuneBIO
11.10.1 INmuneBIO Company Detail
11.10.2 INmuneBIO Business Overview
11.10.3 INmuneBIO Dementia and Alzheimer’s Disease Treatment Introduction
11.10.4 INmuneBIO Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
11.10.5 INmuneBIO Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Cholinesterase Inhibitors
1.2.3 Memantine
1.2.4 Combination Drugs
1.3 Market by Application
1.3.1 Global Dementia and Alzheimer’s Disease Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Dementia and Alzheimer’s Disease Treatment Market Perspective (2018-2029)
2.2 Dementia and Alzheimer’s Disease Treatment Growth Trends by Region
2.2.1 Global Dementia and Alzheimer’s Disease Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Dementia and Alzheimer’s Disease Treatment Historic Market Size by Region (2018-2023)
2.2.3 Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Region (2024-2029)
2.3 Dementia and Alzheimer’s Disease Treatment Market Dynamics
2.3.1 Dementia and Alzheimer’s Disease Treatment Industry Trends
2.3.2 Dementia and Alzheimer’s Disease Treatment Market Drivers
2.3.3 Dementia and Alzheimer’s Disease Treatment Market Challenges
2.3.4 Dementia and Alzheimer’s Disease Treatment Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Dementia and Alzheimer’s Disease Treatment Players by Revenue
3.1.1 Global Top Dementia and Alzheimer’s Disease Treatment Players by Revenue (2018-2023)
3.1.2 Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Dementia and Alzheimer’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dementia and Alzheimer’s Disease Treatment Revenue
3.4 Global Dementia and Alzheimer’s Disease Treatment Market Concentration Ratio
3.4.1 Global Dementia and Alzheimer’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dementia and Alzheimer’s Disease Treatment Revenue in 2022
3.5 Dementia and Alzheimer’s Disease Treatment Key Players Head office and Area Served
3.6 Key Players Dementia and Alzheimer’s Disease Treatment Product Solution and Service
3.7 Date of Enter into Dementia and Alzheimer’s Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 DEMENTIA AND ALZHEIMER’S DISEASE TREATMENT BREAKDOWN DATA BY TYPE
4.1 Global Dementia and Alzheimer’s Disease Treatment Historic Market Size by Type (2018-2023)
4.2 Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Type (2024-2029)
5 DEMENTIA AND ALZHEIMER’S DISEASE TREATMENT BREAKDOWN DATA BY APPLICATION
5.1 Global Dementia and Alzheimer’s Disease Treatment Historic Market Size by Application (2018-2023)
5.2 Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Dementia and Alzheimer’s Disease Treatment Market Size (2018-2029)
6.2 North America Dementia and Alzheimer’s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2018-2023)
6.4 North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Dementia and Alzheimer’s Disease Treatment Market Size (2018-2029)
7.2 Europe Dementia and Alzheimer’s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2018-2023)
7.4 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size (2018-2029)
8.2 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Dementia and Alzheimer’s Disease Treatment Market Size (2018-2029)
9.2 Latin America Dementia and Alzheimer’s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2018-2023)
9.4 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size (2018-2029)
10.2 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Dementia and Alzheimer’s Disease Treatment Introduction
11.1.4 Novartis Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
11.1.5 Novartis Recent Development
11.2 Pfizer, Inc.
11.2.1 Pfizer, Inc. Company Detail
11.2.2 Pfizer, Inc. Business Overview
11.2.3 Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Introduction
11.2.4 Pfizer, Inc. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
11.2.5 Pfizer, Inc. Recent Development
11.3 AbbVie Inc.
11.3.1 AbbVie Inc. Company Detail
11.3.2 AbbVie Inc. Business Overview
11.3.3 AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Introduction
11.3.4 AbbVie Inc. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
11.3.5 AbbVie Inc. Recent Development
11.4 Allergan plc
11.4.1 Allergan plc Company Detail
11.4.2 Allergan plc Business Overview
11.4.3 Allergan plc Dementia and Alzheimer’s Disease Treatment Introduction
11.4.4 Allergan plc Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
11.4.5 Allergan plc Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Detail
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Introduction
11.5.4 Eli Lilly and Company Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
11.5.5 Eli Lilly and Company Recent Development
11.6 F. Hoffmann-La Roche Ltd.
11.6.1 F. Hoffmann-La Roche Ltd. Company Detail
11.6.2 F. Hoffmann-La Roche Ltd. Business Overview
11.6.3 F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Introduction
11.6.4 F. Hoffmann-La Roche Ltd. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
11.6.5 F. Hoffmann-La Roche Ltd. Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Dementia and Alzheimer’s Disease Treatment Introduction
11.7.4 AstraZeneca Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
11.7.5 AstraZeneca Recent Development
11.8 Biogen
11.8.1 Biogen Company Detail
11.8.2 Biogen Business Overview
11.8.3 Biogen Dementia and Alzheimer’s Disease Treatment Introduction
11.8.4 Biogen Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
11.8.5 Biogen Recent Development
11.9 Eisai Co., Ltd.
11.9.1 Eisai Co., Ltd. Company Detail
11.9.2 Eisai Co., Ltd. Business Overview
11.9.3 Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Introduction
11.9.4 Eisai Co., Ltd. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
11.9.5 Eisai Co., Ltd. Recent Development
11.10 INmuneBIO
11.10.1 INmuneBIO Company Detail
11.10.2 INmuneBIO Business Overview
11.10.3 INmuneBIO Dementia and Alzheimer’s Disease Treatment Introduction
11.10.4 INmuneBIO Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
11.10.5 INmuneBIO Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Cholinesterase Inhibitors
Table 3. Key Players of Memantine
Table 4. Key Players of Combination Drugs
Table 5. Global Dementia and Alzheimer’s Disease Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Dementia and Alzheimer’s Disease Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Dementia and Alzheimer’s Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Dementia and Alzheimer’s Disease Treatment Market Share by Region (2018-2023)
Table 9. Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Dementia and Alzheimer’s Disease Treatment Market Share by Region (2024-2029)
Table 11. Dementia and Alzheimer’s Disease Treatment Market Trends
Table 12. Dementia and Alzheimer’s Disease Treatment Market Drivers
Table 13. Dementia and Alzheimer’s Disease Treatment Market Challenges
Table 14. Dementia and Alzheimer’s Disease Treatment Market Restraints
Table 15. Global Dementia and Alzheimer’s Disease Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Dementia and Alzheimer’s Disease Treatment Market Share by Players (2018-2023)
Table 17. Global Top Dementia and Alzheimer’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dementia and Alzheimer’s Disease Treatment as of 2022)
Table 18. Ranking of Global Top Dementia and Alzheimer’s Disease Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Dementia and Alzheimer’s Disease Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Dementia and Alzheimer’s Disease Treatment Product Solution and Service
Table 22. Date of Enter into Dementia and Alzheimer’s Disease Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Dementia and Alzheimer’s Disease Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Type (2024-2029)
Table 28. Global Dementia and Alzheimer’s Disease Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Application (2018-2023)
Table 30. Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Application (2024-2029)
Table 32. North America Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. Novartis Company Detail
Table 48. Novartis Business Overview
Table 49. Novartis Dementia and Alzheimer’s Disease Treatment Product
Table 50. Novartis Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 51. Novartis Recent Development
Table 52. Pfizer, Inc. Company Detail
Table 53. Pfizer, Inc. Business Overview
Table 54. Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Product
Table 55. Pfizer, Inc. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 56. Pfizer, Inc. Recent Development
Table 57. AbbVie Inc. Company Detail
Table 58. AbbVie Inc. Business Overview
Table 59. AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Product
Table 60. AbbVie Inc. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 61. AbbVie Inc. Recent Development
Table 62. Allergan plc Company Detail
Table 63. Allergan plc Business Overview
Table 64. Allergan plc Dementia and Alzheimer’s Disease Treatment Product
Table 65. Allergan plc Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 66. Allergan plc Recent Development
Table 67. Eli Lilly and Company Company Detail
Table 68. Eli Lilly and Company Business Overview
Table 69. Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Product
Table 70. Eli Lilly and Company Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 71. Eli Lilly and Company Recent Development
Table 72. F. Hoffmann-La Roche Ltd. Company Detail
Table 73. F. Hoffmann-La Roche Ltd. Business Overview
Table 74. F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Product
Table 75. F. Hoffmann-La Roche Ltd. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 76. F. Hoffmann-La Roche Ltd. Recent Development
Table 77. AstraZeneca Company Detail
Table 78. AstraZeneca Business Overview
Table 79. AstraZeneca Dementia and Alzheimer’s Disease Treatment Product
Table 80. AstraZeneca Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 81. AstraZeneca Recent Development
Table 82. Biogen Company Detail
Table 83. Biogen Business Overview
Table 84. Biogen Dementia and Alzheimer’s Disease Treatment Product
Table 85. Biogen Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 86. Biogen Recent Development
Table 87. Eisai Co., Ltd. Company Detail
Table 88. Eisai Co., Ltd. Business Overview
Table 89. Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Product
Table 90. Eisai Co., Ltd. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 91. Eisai Co., Ltd. Recent Development
Table 92. INmuneBIO Company Detail
Table 93. INmuneBIO Business Overview
Table 94. INmuneBIO Dementia and Alzheimer’s Disease Treatment Product
Table 95. INmuneBIO Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 96. INmuneBIO Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 1. Global Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Cholinesterase Inhibitors
Table 3. Key Players of Memantine
Table 4. Key Players of Combination Drugs
Table 5. Global Dementia and Alzheimer’s Disease Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Dementia and Alzheimer’s Disease Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Dementia and Alzheimer’s Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Dementia and Alzheimer’s Disease Treatment Market Share by Region (2018-2023)
Table 9. Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Dementia and Alzheimer’s Disease Treatment Market Share by Region (2024-2029)
Table 11. Dementia and Alzheimer’s Disease Treatment Market Trends
Table 12. Dementia and Alzheimer’s Disease Treatment Market Drivers
Table 13. Dementia and Alzheimer’s Disease Treatment Market Challenges
Table 14. Dementia and Alzheimer’s Disease Treatment Market Restraints
Table 15. Global Dementia and Alzheimer’s Disease Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Dementia and Alzheimer’s Disease Treatment Market Share by Players (2018-2023)
Table 17. Global Top Dementia and Alzheimer’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dementia and Alzheimer’s Disease Treatment as of 2022)
Table 18. Ranking of Global Top Dementia and Alzheimer’s Disease Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Dementia and Alzheimer’s Disease Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Dementia and Alzheimer’s Disease Treatment Product Solution and Service
Table 22. Date of Enter into Dementia and Alzheimer’s Disease Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Dementia and Alzheimer’s Disease Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Type (2024-2029)
Table 28. Global Dementia and Alzheimer’s Disease Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Application (2018-2023)
Table 30. Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Application (2024-2029)
Table 32. North America Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. Novartis Company Detail
Table 48. Novartis Business Overview
Table 49. Novartis Dementia and Alzheimer’s Disease Treatment Product
Table 50. Novartis Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 51. Novartis Recent Development
Table 52. Pfizer, Inc. Company Detail
Table 53. Pfizer, Inc. Business Overview
Table 54. Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Product
Table 55. Pfizer, Inc. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 56. Pfizer, Inc. Recent Development
Table 57. AbbVie Inc. Company Detail
Table 58. AbbVie Inc. Business Overview
Table 59. AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Product
Table 60. AbbVie Inc. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 61. AbbVie Inc. Recent Development
Table 62. Allergan plc Company Detail
Table 63. Allergan plc Business Overview
Table 64. Allergan plc Dementia and Alzheimer’s Disease Treatment Product
Table 65. Allergan plc Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 66. Allergan plc Recent Development
Table 67. Eli Lilly and Company Company Detail
Table 68. Eli Lilly and Company Business Overview
Table 69. Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Product
Table 70. Eli Lilly and Company Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 71. Eli Lilly and Company Recent Development
Table 72. F. Hoffmann-La Roche Ltd. Company Detail
Table 73. F. Hoffmann-La Roche Ltd. Business Overview
Table 74. F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Product
Table 75. F. Hoffmann-La Roche Ltd. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 76. F. Hoffmann-La Roche Ltd. Recent Development
Table 77. AstraZeneca Company Detail
Table 78. AstraZeneca Business Overview
Table 79. AstraZeneca Dementia and Alzheimer’s Disease Treatment Product
Table 80. AstraZeneca Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 81. AstraZeneca Recent Development
Table 82. Biogen Company Detail
Table 83. Biogen Business Overview
Table 84. Biogen Dementia and Alzheimer’s Disease Treatment Product
Table 85. Biogen Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 86. Biogen Recent Development
Table 87. Eisai Co., Ltd. Company Detail
Table 88. Eisai Co., Ltd. Business Overview
Table 89. Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Product
Table 90. Eisai Co., Ltd. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 91. Eisai Co., Ltd. Recent Development
Table 92. INmuneBIO Company Detail
Table 93. INmuneBIO Business Overview
Table 94. INmuneBIO Dementia and Alzheimer’s Disease Treatment Product
Table 95. INmuneBIO Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 96. INmuneBIO Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Dementia and Alzheimer’s Disease Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Dementia and Alzheimer’s Disease Treatment Market Share by Type: 2022 VS 2029
Figure 3. Cholinesterase Inhibitors Features
Figure 4. Memantine Features
Figure 5. Combination Drugs Features
Figure 6. Global Dementia and Alzheimer’s Disease Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Dementia and Alzheimer’s Disease Treatment Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Dementia and Alzheimer’s Disease Treatment Report Years Considered
Figure 11. Global Dementia and Alzheimer’s Disease Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Dementia and Alzheimer’s Disease Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Dementia and Alzheimer’s Disease Treatment Market Share by Region: 2022 VS 2029
Figure 14. Global Dementia and Alzheimer’s Disease Treatment Market Share by Players in 2022
Figure 15. Global Top Dementia and Alzheimer’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dementia and Alzheimer’s Disease Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Dementia and Alzheimer’s Disease Treatment Revenue in 2022
Figure 17. North America Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Dementia and Alzheimer’s Disease Treatment Market Share by Country (2018-2029)
Figure 19. United States Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Dementia and Alzheimer’s Disease Treatment Market Share by Country (2018-2029)
Figure 23. Germany Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Share by Region (2018-2029)
Figure 31. China Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Dementia and Alzheimer’s Disease Treatment Market Share by Country (2018-2029)
Figure 39. Mexico Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Share by Country (2018-2029)
Figure 43. Turkey Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Novartis Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
Figure 46. Pfizer, Inc. Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
Figure 47. AbbVie Inc. Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
Figure 48. Allergan plc Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
Figure 49. Eli Lilly and Company Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
Figure 50. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
Figure 51. AstraZeneca Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
Figure 52. Biogen Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
Figure 53. Eisai Co., Ltd. Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
Figure 54. INmuneBIO Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Figure 1. Global Dementia and Alzheimer’s Disease Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Dementia and Alzheimer’s Disease Treatment Market Share by Type: 2022 VS 2029
Figure 3. Cholinesterase Inhibitors Features
Figure 4. Memantine Features
Figure 5. Combination Drugs Features
Figure 6. Global Dementia and Alzheimer’s Disease Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Dementia and Alzheimer’s Disease Treatment Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Dementia and Alzheimer’s Disease Treatment Report Years Considered
Figure 11. Global Dementia and Alzheimer’s Disease Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Dementia and Alzheimer’s Disease Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Dementia and Alzheimer’s Disease Treatment Market Share by Region: 2022 VS 2029
Figure 14. Global Dementia and Alzheimer’s Disease Treatment Market Share by Players in 2022
Figure 15. Global Top Dementia and Alzheimer’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dementia and Alzheimer’s Disease Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Dementia and Alzheimer’s Disease Treatment Revenue in 2022
Figure 17. North America Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Dementia and Alzheimer’s Disease Treatment Market Share by Country (2018-2029)
Figure 19. United States Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Dementia and Alzheimer’s Disease Treatment Market Share by Country (2018-2029)
Figure 23. Germany Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Share by Region (2018-2029)
Figure 31. China Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Dementia and Alzheimer’s Disease Treatment Market Share by Country (2018-2029)
Figure 39. Mexico Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Share by Country (2018-2029)
Figure 43. Turkey Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Novartis Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
Figure 46. Pfizer, Inc. Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
Figure 47. AbbVie Inc. Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
Figure 48. Allergan plc Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
Figure 49. Eli Lilly and Company Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
Figure 50. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
Figure 51. AstraZeneca Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
Figure 52. Biogen Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
Figure 53. Eisai Co., Ltd. Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
Figure 54. INmuneBIO Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
